Once Upon a Farm: Can Revenue Momentum Justify Post-IPO Premium or Is Growth Already Priced In

Once Upon a Farm (NYSE: OFRM) reports first-quarter fiscal 2026 results tomorrow, May 7, after market close, with analysts expecting the organic children's food maker to post a loss of $-0.42 per share on revenue of approximately $64.35 million. The central question: can the recently public company sustain the 30% revenue growth momentum from its IPO quarter while narrowing losses toward its full-year profitability target? For a stock trading 16% below its $18 IPO price just three months after going public, this report will test whether the premium valuation assigned to its mission-driven organic food platform can withstand the reality of sustained operating losses.

Part 1: Earnings Preview

Once Upon a Farm is a public benefit corporation that produces organic, cold-pressed baby food pouches, frozen meals, refrigerated oat bars, and snacks for children from infancy through school age, distributed across over 25,000 retail locations. The company went public in February 2026 and positions itself as the fastest-growing brand in the premium children's nutrition category.

OFRM reports first-quarter fiscal 2026 earnings on May 7, 2026, after market close. Analysts expect a loss of $-0.42 per share on revenue of $64.35 million. The company most recently reported fourth-quarter 2025 results on March 12, with actual EPS of $0.11, which met the consensus estimate of $0.11. However, that quarter included a $22.5 million net income swing driven by non-cash derivative liability adjustments related to pre-IPO financing—stripping out those items, the company posted Adjusted EBITDA of $6.6 million. Year-over-year comparisons are unavailable as OFRM was private a year ago.

Three key themes define this earnings story:

Post-IPO execution and the path to profitability: Management guided to full-year 2026 Adjusted EBITDA of $2-4 million on revenue of $302-310 million, implying 25-29% growth. The first quarter will reveal whether the company can balance aggressive distribution expansion—including over 3,200 branded cooler installations—with the cost discipline needed to reach breakeven. Investors will scrutinize whether trade spending and slotting fees for new retail placements continue to pressure gross margins as they did in 2025, when gross margin contracted 125 basis points despite 53.5% revenue growth.

Distribution expansion and velocity metrics: Once Upon a Farm's growth engine depends on converting retail shelf space into sustained household penetration. The company achieved over 430,000 points of distribution by mid-2025 and claims the #1 position in dollar growth within its categories. This quarter will test whether velocity—sales per store—can keep pace with the rapid store count expansion, or whether the company is simply buying shelf space without corresponding consumer pull-through.

Premium pricing power in a value-conscious environment: With a Net Promoter Score of 47 and 73% of buyers rating the brand as trustworthy, OFRM commands premium pricing for organic children's food. But the company faces the challenge of maintaining price/mix gains while competing against lower-priced conventional alternatives in a consumer environment where grocery inflation remains top-of-mind for parents.

Analyst commentary ahead of the release reflects cautious optimism tempered by valuation concerns. Goldman Sachs initiated coverage at Buy with a $43 price target, citing the company's "first-mover advantage in cold-pressed organic baby food and significant runway for category expansion." JPMorgan's Overweight rating with a $29 target emphasizes "strong unit economics and a clear path to sustained profitability as scale benefits emerge." However, TD Cowen's Hold rating at $26 and Barclays' Equalweight at $25 suggest some analysts see limited upside at current levels, with Deutsche Bank cutting its target from $25 to $22 post-Q4 results while maintaining Hold. William Blair's Outperform rating (no price target) highlights "the company's mission-driven brand resonance with millennial parents" as a durable competitive advantage, while Oppenheimer's $35 Outperform target points to "underappreciated operating leverage as the company scales past $300 million in revenue."

Part 2: Historical Earnings Performance

Once Upon a Farm has limited public earnings history, with only one quarter of reported results as a newly public company. In Q4 2025 (reported March 12, 2026), the company posted EPS of $0.11, exactly matching the consensus estimate of $0.11. This represented neither a beat nor a miss, though the headline net income figure of $22.5 million was heavily influenced by non-cash derivative liability adjustments related to pre-IPO financing structures.

With only one data point available, no pattern of beats or misses can be established. The company's Adjusted EBITDA of $6.6 million in Q4 2025 exceeded the $2.2 million posted in the prior-year period, but year-over-year EPS comparisons are not available for quarters prior to the IPO. Investors should note that OFRM's transition from private to public company reporting makes historical earnings patterns less relevant than forward guidance execution.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Once Upon a Farm reports after market close, meaning Day 0 reflects pre-earnings anticipation while Day +1 captures the market's first full reaction to results.

Based on the single earnings event since going public, OFRM exhibited moderate volatility around its Q4 2025 report. The stock declined 1.69% on Day 0 (the session before results) with an intraday range of 8.60%, suggesting pre-announcement jitters. The Day +1 reaction was more pronounced, with the stock falling 7.27% and trading across an 18.67% range as investors digested the company's fiscal 2026 guidance, which disappointed despite the in-line Q4 results. This pattern suggests OFRM's post-earnings moves are driven more by forward guidance and profitability trajectory than by the quarterly beat/miss itself. With only one historical data point, investors should expect elevated volatility as the market continues to establish a trading pattern for this newly public stock.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 11.57% (±$1.69) for the May 15 expiration, which is slightly lower than the 18.67% average Day +1 range observed in the single prior earnings event. This suggests options traders are anticipating meaningful volatility but perhaps less dramatic than the March reaction, when guidance disappointment drove the outsized move. The 130.04% average implied volatility reflects the elevated uncertainty typical of a recently public company with limited trading history.

Part 3: What Analysts Are Saying

Analysts maintain a bullish stance on OFRM with an average rating of 4.09 out of 5.0 (between Buy and Strong Buy), though the consensus is tempered by a meaningful contingent of Hold-rated analysts. The mean price target of $26.44 implies 81% upside from the current price of $14.62, with estimates ranging from a low of $17.00 to a high of $43.00—a wide spread reflecting divergent views on the company's long-term profitability trajectory.

The rating breakdown shows 6 Strong Buy ratings and 5 Hold ratings among the 11 analysts covering the stock, with no Sell or Strong Sell recommendations. This distribution suggests the Street is divided between bulls who see significant upside in the company's category-leading growth and mission-driven brand positioning, and more cautious analysts who view the current valuation as fairly reflecting near-term execution risks given persistent losses.

Sentiment has remained unchanged over the past month, with the 6-0-5-0-0 distribution (Strong Buy-Buy-Hold-Sell-Strong Sell) holding steady. This stability suggests analysts are waiting for first-quarter results and updated guidance before adjusting their views. The lack of any Sell ratings indicates even skeptical analysts see the company's long-term potential, though Hold ratings from firms like TD Cowen, Barclays, and Deutsche Bank reflect concerns about valuation and the path to sustained profitability.

The 81% implied upside to the $26.44 consensus target is substantial, but investors should note the wide target range. Goldman Sachs' $43 target represents 194% upside and reflects maximum bullish conviction in the company's ability to dominate the organic children's food category, while Deutsche Bank's recently lowered $22 target implies 50% upside and suggests more modest expectations. This dispersion underscores the binary nature of OFRM's investment case: if the company executes on its distribution expansion while achieving operating leverage, the stock could re-rate significantly higher; if losses persist and growth disappoints, the premium valuation could compress quickly.

Part 4: Technical Picture

OFRM's technical setup heading into earnings reflects the challenging post-IPO period, with the stock trading below all major moving averages. The current price of $14.62 sits below the 5-day MA of $14.91, the 10-day MA of $14.80, the 20-day MA of $15.23, and significantly below the 50-day MA of $17.41. This alignment of moving averages in descending order indicates a clear downtrend since the February IPO, with the stock failing to establish support at any meaningful technical level.

Barchart Technical Opinion data is not available for this recently public stock, preventing a comprehensive view of short-term, medium-term, and long-term trend signals. The absence of 100-day and 200-day moving averages further reflects OFRM's limited trading history—the stock has been public for only three months.

The downward-sloping moving average structure suggests persistent selling pressure as early IPO investors and insiders potentially take profits or cut losses. The stock's inability to reclaim even the short-term 5-day and 10-day moving averages indicates weak near-term momentum. The widening gap between the current price ($14.62) and the 50-day MA ($17.41)—a 16% discount—shows accelerating technical deterioration rather than stabilization.

Key technical levels to watch include the $14.80 area (10-day MA) as immediate resistance and the $17.41 level (50-day MA) as a more significant hurdle that would need to be reclaimed to signal a trend reversal. On the downside, the stock is testing its post-IPO lows near $14.60, with the $18 IPO price now serving as distant overhead resistance. The overall technical setup is cautionary heading into earnings, as the stock enters the event in a confirmed downtrend with no nearby support levels. A positive earnings surprise and strong guidance would need to be substantial to overcome the negative technical momentum, while any disappointment could accelerate the decline given the lack of technical support. The 11.57% expected move suggests the market is pricing in meaningful volatility, but the bearish technical backdrop means the risk/reward may be skewed to the downside unless results significantly exceed expectations.